DKK3 and sarcopenia: Additionally, other studies have shown that sarcopenia significantly impacts patients with chronic obstructive pulmonary disease, exacerbating their morbidity and mortality and suggesting that Dickkopf-3 could be a potential target for the diagnosis and treatment of sarcopenia in COPD patients (36, 37).